TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SVRA

Savara Inc

Healthcare · Biotechnology

5.40$ -0.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement SVRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-96.5% +740,640.7% -100.0% -99.6% -100.0%
+5,504.1% -95.6% +44.9% +7,272.8% -9.7% -17.3% -3.8% +58.8% +76.3% -99.7%
-9,528.0% -190.8%
+45.4% -71.1% +126.3% +100.8% +4.3% -9.7% -17.3% -3.8% +58.8% +76.3% +4.3%
+15.5% -74.3% +292.9% -3.9% +20.7% -7.0% +3.2% -11.5% +43.4% +59.8% +68.0%
+35.7% -71.2% +164.0% +61.4% -16.8% -63.9% -14.0% -12.2% +43.7% +59.8% +389.9%
-22.4% +148.1% -99.1% +536.4% +2,017.1% +54.0% -96.1%
-175.5% -94.5% +54.0% -65.1% +0.1%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?